ARTA
RMD icon

A.R.T. Advisors’s ResMed RMD Stock Holding History

A.R.T. Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,310
Closed -$1.6M – 790
2019
Q4 		$1.6M Buy
+10,310
New +$1.49M 0.08% 382
2017
Q2 		– Sell
-5,900
Closed -$424K – 1672
2017
Q1 		$424K Buy
+5,900
New +$408K 0.02% 867
2014
Q1 		– Sell
-15,950
Closed -$750K – 1520
2013
Q4 		$750K Buy
+15,950
New +$807K 0.04% 610
2013
Q3 		– Sell
-60,127
Closed -$2.71M – 1459
2013
Q2 		$2.71M Buy
+60,127
New +$2.85M 0.09% 315

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

A.R.T. Advisors's RMD Position: Q1 2020 in Review

A.R.T. Advisors sold out of ResMed (RMD) in Q1 2020, closing a stake of 10,310 shares — an estimated $1.6M sold.

A.R.T. Advisors first reported a position in RMD in Q2 2013 and held it in 4 quarters. The position peaked at $2.71M in Q2 2013. 584 funds tracked by Wall St. Rank hold RMD as of Q1 2020.

  • A.R.T. Advisors reported no remaining ResMed position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 10,310 ResMed shares in Q1 2020, an estimated $1.6M.
  • A.R.T. Advisors first reported a position in ResMed in Q2 2013 and held it in 4 quarters.
  • A.R.T. Advisors's ResMed position peaked at $2.71M in Q2 2013.
  • 584 funds tracked by Wall St. Rank held ResMed as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.